Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7494
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc (PVCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 10
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 11
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 12
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 13
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 14
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 15
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 16
Provectus Biopharmaceuticals Inc – Key Competitors 17
Provectus Biopharmaceuticals Inc – Key Employees 18
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 20
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Provectus Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 10
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 11
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 12
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 13
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 14
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 15
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 16
Provectus Biopharmaceuticals Inc, Key Competitors 17
Provectus Biopharmaceuticals Inc, Key Employees 18
Provectus Biopharmaceuticals Inc, Subsidiaries 19

List of Figures
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Black Knight Inc (BKI):企業の財務・戦略的SWOT分析
    Black Knight Inc (BKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • FieldPoint Petroleum Corp (FPP):企業の財務・戦略的SWOT分析
    Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working interests in exploration areas. Its properties comprise South Vacuum field, Block A-49 and Block 6 field, Fly …
  • Carlisle Companies Inc:企業の戦略・SWOT・財務情報
    Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Coeur Mining Inc
    Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • DHX Media Ltd.:企業の戦略・SWOT・財務情報
    DHX Media Ltd. - Strategy, SWOT and Corporate Finance Report Summary DHX Media Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eurobio Scientific SA (ALERS):企業の製品パイプライン分析
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. …
  • Cordis Corp-医療機器分野:企業M&A・提携分析
    Summary Cordis Corporation (Cordis), a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surgery. The company’s cardiology portfolio comprises sheaths, diagnostic guidewires, diagnostic cathet …
  • BioVentrix Inc-医療機器分野:企業M&A・提携分析
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company provides revivent myocardial anchoring systems that restore the size, volume and resulting function of the left ventricle for improving cardiac function in heart fa …
  • Translate Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • mixi, Inc.:企業の戦略・SWOT・財務分析
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • New York & Company, Inc.:企業の戦略・SWOT・財務情報
    New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Orkuveita Reykjavikur:電力:M&Aディール及び事業提携情報
    Summary Orkuveita Reykjavikur (Orkuveita) is a public utility company that provides electricity and water. The company generates and supplies electricity. It harnesses hot water from geothermal fields and supplies it for heating applications. The company also supplies cold water from its groundwater …
  • Capita plc:企業の戦略・SWOT・財務分析
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆